---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-036741"
form_type: "8-K"
ticker: "OM"
cik: "0001484612"
company_name: "Outset Medical, Inc."
filed_at: "2025-02-26T23:59:59+00:00"
generated_at: "2026-05-26T03:30:34.466515+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Outset Medical receives second Nasdaq delisting notice; FY2024 revenue $113.7M, down 13%

## Summary
- Nasdaq notified Outset on Feb 24, 2025 of non-compliance with $1.00 minimum bid price; 180-day cure period until Aug 25, 2025.
- Stockholders to vote on reverse stock split (ratio 1:10 to 1:15) at special meeting March 5, 2025.
- FY2024 total revenue $113.7M, down 12.8% from $130.4M in 2023; product revenue fell 21.7% to $81.0M.
- Net loss narrowed to $128.0M ($2.46 loss per share) from $172.8M ($3.48) in 2023; cash rose to $124.0M from $68.5M.
- Term loan balance increased to $197.4M from $130.1M; accumulated deficit reached $1.09B.

## SEC filing metadata
- accession: 0001193125-25-036741
- form_type: 8-K
- ticker: OM
- cik: 0001484612
- company_name: Outset Medical, Inc.
- filed_at: 2025-02-26T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484612/000119312525036741/0001193125-25-036741-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484612/000119312525036741/d122047d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-036741
- JSON: https://secwatch.observer/filing/0001193125-25-036741.json
- Plain text: https://secwatch.observer/filing/0001193125-25-036741.txt

## Key facts
- Listing & Compliance Notices
  Outset Medical, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: noncompliance notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1), 5810(c)(3)(A)
  source text: February 24, 2025, the Company received a second notice (the “Notice”) from Nasdaq of failure to comply with the minimum bid price requirement. The Notice has no immediate effect on the listing of the Company’s common stock on the Nasdaq Global Select Market, which will continue to trade on the Nasdaq Global Select Market. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial compliance period of 180 calendar days, or until August 25, 2025, to regain compliance with the minimum bid price requirement. To regain compliance, the closing bid price of the Company’s
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484612/000119312525036741/0001193125-25-036741-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.